Stryker Corporation: Hold For Quality, Wait For The Dip (NYSE:SYK)
· seekingalpha.com
Stryker is a MedTech compounder with 11% organic revenue growth and expanding margins. Click here to read why SYK stock is a Hold.
About Me & Investment Background I am a finance professional based in Munich, Germany, currently working as a Investment Manager within a major European insuran...